Skip to main content
. Author manuscript; available in PMC: 2009 Nov 7.
Published in final edited form as: Oncogene. 2009 Mar 23;28(18):1941–1948. doi: 10.1038/onc.2009.37

Fig. 3. The role of Gadd45gip1 in NAC-1-mediated paclitaxel resistance.

Fig. 3

A. The level of Gadd45gip1 mRNA as determined by quantitative real-time RT-PCR was decreased in paclitaxel-resistant OVCAR3, A2780 and SKOV3 cells as compared to the parental naïve counterparts. B. The efficiency of Gadd45gip1 shRNA in reducing its mRNA level is demonstrated by quantitative real-time RT-PCR in paclitaxel-resistant SKOV3 cells. The level of Gadd45gip1 expression was normalized to that of GAPDH.

C. Reducing Gadd45gip1 by shRNA in cells increases paclitaxel resistance as compared to control shRNA treatment.

HHS Vulnerability Disclosure